DISEASE MARKERS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=958807, encodeId=acd095880e5a, content=偏重的研究方向：肿瘤 经验分享：有人跟我一样三个月了连审稿人都没有的吗？害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1875413047, createdName=ms7000000322107334, createdTime=Tue Apr 20 18:00:47 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242321, encodeId=dce0124232100, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=马-龙, createdTime=Wed Aug 31 17:24:03 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227861, encodeId=47c9122e86161, content=投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a76430084, createdName=ms3000000091174664, createdTime=Tue Jun 21 22:11:31 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944079, encodeId=5a269440e9e2, content=请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Sun Feb 28 08:29:25 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919514, encodeId=1241919514db, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41072429587, createdName=123b2bbam96暂无昵称, createdTime=Sun Jan 24 18:32:16 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096197, encodeId=1866209619e86, content=submitted差不多2周了，还是editor unassigned 不知道要多久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Wed Oct 26 07:22:22 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104385, encodeId=cd05210438598, content=偏重的研究方向：网药;病理学 经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=780b8246335, createdName=ms7000002026112309, createdTime=Mon Dec 05 12:49:07 CST 2022, time=2022-12-05, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238535, encodeId=c41c123853511, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤方向;meta-analysis 经验分享：2022.5.30提交 2022.7.17返修 2022.7.24回修完成 2022.8.13接受 感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22546576496, createdName=ms5000000843589302, createdTime=Sat Aug 13 21:24:43 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589369, encodeId=dc13589369b1, content=一直显示 pending approve 什么意思啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/amodRXMprCWV9f2xZ5KibibeL361ffy7OTCYbicgKiayK7b1bVNLdgsP3VKZLDMTfohbzHDnOcS6WHiaq7MAGDggrLw/132, createdBy=69ab2341096, createdName=wwlqd, createdTime=Tue Apr 21 10:49:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093944, encodeId=9e4f20939440e, content=偏重的研究方向：生信 经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=124a12bbm27暂无昵称, createdTime=Sat Oct 15 17:37:52 CST 2022, time=2022-10-15, status=1, ipAttribution=)]

2021-04-20 ms7000000322107334

偏重的研究方向：肿瘤
经验分享：有人跟我一样三个月了连审稿人都没有的吗？害

50 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=958807, encodeId=acd095880e5a, content=偏重的研究方向：肿瘤 经验分享：有人跟我一样三个月了连审稿人都没有的吗？害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1875413047, createdName=ms7000000322107334, createdTime=Tue Apr 20 18:00:47 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242321, encodeId=dce0124232100, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=马-龙, createdTime=Wed Aug 31 17:24:03 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227861, encodeId=47c9122e86161, content=投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a76430084, createdName=ms3000000091174664, createdTime=Tue Jun 21 22:11:31 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944079, encodeId=5a269440e9e2, content=请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Sun Feb 28 08:29:25 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919514, encodeId=1241919514db, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41072429587, createdName=123b2bbam96暂无昵称, createdTime=Sun Jan 24 18:32:16 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096197, encodeId=1866209619e86, content=submitted差不多2周了，还是editor unassigned 不知道要多久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Wed Oct 26 07:22:22 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104385, encodeId=cd05210438598, content=偏重的研究方向：网药;病理学 经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=780b8246335, createdName=ms7000002026112309, createdTime=Mon Dec 05 12:49:07 CST 2022, time=2022-12-05, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238535, encodeId=c41c123853511, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤方向;meta-analysis 经验分享：2022.5.30提交 2022.7.17返修 2022.7.24回修完成 2022.8.13接受 感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22546576496, createdName=ms5000000843589302, createdTime=Sat Aug 13 21:24:43 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589369, encodeId=dc13589369b1, content=一直显示 pending approve 什么意思啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/amodRXMprCWV9f2xZ5KibibeL361ffy7OTCYbicgKiayK7b1bVNLdgsP3VKZLDMTfohbzHDnOcS6WHiaq7MAGDggrLw/132, createdBy=69ab2341096, createdName=wwlqd, createdTime=Tue Apr 21 10:49:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093944, encodeId=9e4f20939440e, content=偏重的研究方向：生信 经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=124a12bbm27暂无昵称, createdTime=Sat Oct 15 17:37:52 CST 2022, time=2022-10-15, status=1, ipAttribution=)]

2022-08-31 马-龙

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤;生信
经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?

35 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=958807, encodeId=acd095880e5a, content=偏重的研究方向：肿瘤 经验分享：有人跟我一样三个月了连审稿人都没有的吗？害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1875413047, createdName=ms7000000322107334, createdTime=Tue Apr 20 18:00:47 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242321, encodeId=dce0124232100, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=马-龙, createdTime=Wed Aug 31 17:24:03 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227861, encodeId=47c9122e86161, content=投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a76430084, createdName=ms3000000091174664, createdTime=Tue Jun 21 22:11:31 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944079, encodeId=5a269440e9e2, content=请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Sun Feb 28 08:29:25 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919514, encodeId=1241919514db, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41072429587, createdName=123b2bbam96暂无昵称, createdTime=Sun Jan 24 18:32:16 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096197, encodeId=1866209619e86, content=submitted差不多2周了，还是editor unassigned 不知道要多久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Wed Oct 26 07:22:22 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104385, encodeId=cd05210438598, content=偏重的研究方向：网药;病理学 经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=780b8246335, createdName=ms7000002026112309, createdTime=Mon Dec 05 12:49:07 CST 2022, time=2022-12-05, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238535, encodeId=c41c123853511, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤方向;meta-analysis 经验分享：2022.5.30提交 2022.7.17返修 2022.7.24回修完成 2022.8.13接受 感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22546576496, createdName=ms5000000843589302, createdTime=Sat Aug 13 21:24:43 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589369, encodeId=dc13589369b1, content=一直显示 pending approve 什么意思啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/amodRXMprCWV9f2xZ5KibibeL361ffy7OTCYbicgKiayK7b1bVNLdgsP3VKZLDMTfohbzHDnOcS6WHiaq7MAGDggrLw/132, createdBy=69ab2341096, createdName=wwlqd, createdTime=Tue Apr 21 10:49:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093944, encodeId=9e4f20939440e, content=偏重的研究方向：生信 经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=124a12bbm27暂无昵称, createdTime=Sat Oct 15 17:37:52 CST 2022, time=2022-10-15, status=1, ipAttribution=)]

2022-06-21 ms3000000091174664

投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作

36 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=958807, encodeId=acd095880e5a, content=偏重的研究方向：肿瘤 经验分享：有人跟我一样三个月了连审稿人都没有的吗？害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1875413047, createdName=ms7000000322107334, createdTime=Tue Apr 20 18:00:47 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242321, encodeId=dce0124232100, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=马-龙, createdTime=Wed Aug 31 17:24:03 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227861, encodeId=47c9122e86161, content=投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a76430084, createdName=ms3000000091174664, createdTime=Tue Jun 21 22:11:31 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944079, encodeId=5a269440e9e2, content=请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Sun Feb 28 08:29:25 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919514, encodeId=1241919514db, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41072429587, createdName=123b2bbam96暂无昵称, createdTime=Sun Jan 24 18:32:16 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096197, encodeId=1866209619e86, content=submitted差不多2周了，还是editor unassigned 不知道要多久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Wed Oct 26 07:22:22 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104385, encodeId=cd05210438598, content=偏重的研究方向：网药;病理学 经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=780b8246335, createdName=ms7000002026112309, createdTime=Mon Dec 05 12:49:07 CST 2022, time=2022-12-05, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238535, encodeId=c41c123853511, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤方向;meta-analysis 经验分享：2022.5.30提交 2022.7.17返修 2022.7.24回修完成 2022.8.13接受 感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22546576496, createdName=ms5000000843589302, createdTime=Sat Aug 13 21:24:43 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589369, encodeId=dc13589369b1, content=一直显示 pending approve 什么意思啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/amodRXMprCWV9f2xZ5KibibeL361ffy7OTCYbicgKiayK7b1bVNLdgsP3VKZLDMTfohbzHDnOcS6WHiaq7MAGDggrLw/132, createdBy=69ab2341096, createdName=wwlqd, createdTime=Tue Apr 21 10:49:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093944, encodeId=9e4f20939440e, content=偏重的研究方向：生信 经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=124a12bbm27暂无昵称, createdTime=Sat Oct 15 17:37:52 CST 2022, time=2022-10-15, status=1, ipAttribution=)]

2021-02-28 1258c620m14暂无昵称

请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？

101 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=958807, encodeId=acd095880e5a, content=偏重的研究方向：肿瘤 经验分享：有人跟我一样三个月了连审稿人都没有的吗？害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1875413047, createdName=ms7000000322107334, createdTime=Tue Apr 20 18:00:47 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242321, encodeId=dce0124232100, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=马-龙, createdTime=Wed Aug 31 17:24:03 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227861, encodeId=47c9122e86161, content=投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a76430084, createdName=ms3000000091174664, createdTime=Tue Jun 21 22:11:31 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944079, encodeId=5a269440e9e2, content=请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Sun Feb 28 08:29:25 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919514, encodeId=1241919514db, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41072429587, createdName=123b2bbam96暂无昵称, createdTime=Sun Jan 24 18:32:16 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096197, encodeId=1866209619e86, content=submitted差不多2周了，还是editor unassigned 不知道要多久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Wed Oct 26 07:22:22 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104385, encodeId=cd05210438598, content=偏重的研究方向：网药;病理学 经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=780b8246335, createdName=ms7000002026112309, createdTime=Mon Dec 05 12:49:07 CST 2022, time=2022-12-05, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238535, encodeId=c41c123853511, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤方向;meta-analysis 经验分享：2022.5.30提交 2022.7.17返修 2022.7.24回修完成 2022.8.13接受 感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22546576496, createdName=ms5000000843589302, createdTime=Sat Aug 13 21:24:43 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589369, encodeId=dc13589369b1, content=一直显示 pending approve 什么意思啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/amodRXMprCWV9f2xZ5KibibeL361ffy7OTCYbicgKiayK7b1bVNLdgsP3VKZLDMTfohbzHDnOcS6WHiaq7MAGDggrLw/132, createdBy=69ab2341096, createdName=wwlqd, createdTime=Tue Apr 21 10:49:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093944, encodeId=9e4f20939440e, content=偏重的研究方向：生信 经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=124a12bbm27暂无昵称, createdTime=Sat Oct 15 17:37:52 CST 2022, time=2022-10-15, status=1, ipAttribution=)]

2021-01-24 123b2bbam96暂无昵称

审稿速度:6.0 | 投稿命中率:75.0
经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。

91 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=958807, encodeId=acd095880e5a, content=偏重的研究方向：肿瘤 经验分享：有人跟我一样三个月了连审稿人都没有的吗？害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1875413047, createdName=ms7000000322107334, createdTime=Tue Apr 20 18:00:47 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242321, encodeId=dce0124232100, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=马-龙, createdTime=Wed Aug 31 17:24:03 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227861, encodeId=47c9122e86161, content=投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a76430084, createdName=ms3000000091174664, createdTime=Tue Jun 21 22:11:31 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944079, encodeId=5a269440e9e2, content=请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Sun Feb 28 08:29:25 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919514, encodeId=1241919514db, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41072429587, createdName=123b2bbam96暂无昵称, createdTime=Sun Jan 24 18:32:16 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096197, encodeId=1866209619e86, content=submitted差不多2周了，还是editor unassigned 不知道要多久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Wed Oct 26 07:22:22 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104385, encodeId=cd05210438598, content=偏重的研究方向：网药;病理学 经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=780b8246335, createdName=ms7000002026112309, createdTime=Mon Dec 05 12:49:07 CST 2022, time=2022-12-05, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238535, encodeId=c41c123853511, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤方向;meta-analysis 经验分享：2022.5.30提交 2022.7.17返修 2022.7.24回修完成 2022.8.13接受 感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22546576496, createdName=ms5000000843589302, createdTime=Sat Aug 13 21:24:43 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589369, encodeId=dc13589369b1, content=一直显示 pending approve 什么意思啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/amodRXMprCWV9f2xZ5KibibeL361ffy7OTCYbicgKiayK7b1bVNLdgsP3VKZLDMTfohbzHDnOcS6WHiaq7MAGDggrLw/132, createdBy=69ab2341096, createdName=wwlqd, createdTime=Tue Apr 21 10:49:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093944, encodeId=9e4f20939440e, content=偏重的研究方向：生信 经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=124a12bbm27暂无昵称, createdTime=Sat Oct 15 17:37:52 CST 2022, time=2022-10-15, status=1, ipAttribution=)]

2022-10-26 科研小蔡姬

submitted差不多2周了，还是editor unassigned 不知道要多久了

39 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=958807, encodeId=acd095880e5a, content=偏重的研究方向：肿瘤 经验分享：有人跟我一样三个月了连审稿人都没有的吗？害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1875413047, createdName=ms7000000322107334, createdTime=Tue Apr 20 18:00:47 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242321, encodeId=dce0124232100, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=马-龙, createdTime=Wed Aug 31 17:24:03 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227861, encodeId=47c9122e86161, content=投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a76430084, createdName=ms3000000091174664, createdTime=Tue Jun 21 22:11:31 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944079, encodeId=5a269440e9e2, content=请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Sun Feb 28 08:29:25 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919514, encodeId=1241919514db, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41072429587, createdName=123b2bbam96暂无昵称, createdTime=Sun Jan 24 18:32:16 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096197, encodeId=1866209619e86, content=submitted差不多2周了，还是editor unassigned 不知道要多久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Wed Oct 26 07:22:22 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104385, encodeId=cd05210438598, content=偏重的研究方向：网药;病理学 经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=780b8246335, createdName=ms7000002026112309, createdTime=Mon Dec 05 12:49:07 CST 2022, time=2022-12-05, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238535, encodeId=c41c123853511, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤方向;meta-analysis 经验分享：2022.5.30提交 2022.7.17返修 2022.7.24回修完成 2022.8.13接受 感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22546576496, createdName=ms5000000843589302, createdTime=Sat Aug 13 21:24:43 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589369, encodeId=dc13589369b1, content=一直显示 pending approve 什么意思啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/amodRXMprCWV9f2xZ5KibibeL361ffy7OTCYbicgKiayK7b1bVNLdgsP3VKZLDMTfohbzHDnOcS6WHiaq7MAGDggrLw/132, createdBy=69ab2341096, createdName=wwlqd, createdTime=Tue Apr 21 10:49:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093944, encodeId=9e4f20939440e, content=偏重的研究方向：生信 经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=124a12bbm27暂无昵称, createdTime=Sat Oct 15 17:37:52 CST 2022, time=2022-10-15, status=1, ipAttribution=)]

2022-12-05 ms7000002026112309 来自安徽省

偏重的研究方向：网药;病理学
经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集

38 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=958807, encodeId=acd095880e5a, content=偏重的研究方向：肿瘤 经验分享：有人跟我一样三个月了连审稿人都没有的吗？害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1875413047, createdName=ms7000000322107334, createdTime=Tue Apr 20 18:00:47 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242321, encodeId=dce0124232100, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=马-龙, createdTime=Wed Aug 31 17:24:03 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227861, encodeId=47c9122e86161, content=投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a76430084, createdName=ms3000000091174664, createdTime=Tue Jun 21 22:11:31 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944079, encodeId=5a269440e9e2, content=请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Sun Feb 28 08:29:25 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919514, encodeId=1241919514db, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41072429587, createdName=123b2bbam96暂无昵称, createdTime=Sun Jan 24 18:32:16 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096197, encodeId=1866209619e86, content=submitted差不多2周了，还是editor unassigned 不知道要多久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Wed Oct 26 07:22:22 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104385, encodeId=cd05210438598, content=偏重的研究方向：网药;病理学 经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=780b8246335, createdName=ms7000002026112309, createdTime=Mon Dec 05 12:49:07 CST 2022, time=2022-12-05, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238535, encodeId=c41c123853511, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤方向;meta-analysis 经验分享：2022.5.30提交 2022.7.17返修 2022.7.24回修完成 2022.8.13接受 感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22546576496, createdName=ms5000000843589302, createdTime=Sat Aug 13 21:24:43 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589369, encodeId=dc13589369b1, content=一直显示 pending approve 什么意思啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/amodRXMprCWV9f2xZ5KibibeL361ffy7OTCYbicgKiayK7b1bVNLdgsP3VKZLDMTfohbzHDnOcS6WHiaq7MAGDggrLw/132, createdBy=69ab2341096, createdName=wwlqd, createdTime=Tue Apr 21 10:49:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093944, encodeId=9e4f20939440e, content=偏重的研究方向：生信 经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=124a12bbm27暂无昵称, createdTime=Sat Oct 15 17:37:52 CST 2022, time=2022-10-15, status=1, ipAttribution=)]

2022-08-13 ms5000000843589302

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤方向;meta-analysis
经验分享：2022.5.30提交
2022.7.17返修
2022.7.24回修完成
2022.8.13接受
感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。

45 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=958807, encodeId=acd095880e5a, content=偏重的研究方向：肿瘤 经验分享：有人跟我一样三个月了连审稿人都没有的吗？害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1875413047, createdName=ms7000000322107334, createdTime=Tue Apr 20 18:00:47 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242321, encodeId=dce0124232100, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=马-龙, createdTime=Wed Aug 31 17:24:03 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227861, encodeId=47c9122e86161, content=投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a76430084, createdName=ms3000000091174664, createdTime=Tue Jun 21 22:11:31 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944079, encodeId=5a269440e9e2, content=请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Sun Feb 28 08:29:25 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919514, encodeId=1241919514db, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41072429587, createdName=123b2bbam96暂无昵称, createdTime=Sun Jan 24 18:32:16 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096197, encodeId=1866209619e86, content=submitted差不多2周了，还是editor unassigned 不知道要多久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Wed Oct 26 07:22:22 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104385, encodeId=cd05210438598, content=偏重的研究方向：网药;病理学 经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=780b8246335, createdName=ms7000002026112309, createdTime=Mon Dec 05 12:49:07 CST 2022, time=2022-12-05, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238535, encodeId=c41c123853511, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤方向;meta-analysis 经验分享：2022.5.30提交 2022.7.17返修 2022.7.24回修完成 2022.8.13接受 感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22546576496, createdName=ms5000000843589302, createdTime=Sat Aug 13 21:24:43 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589369, encodeId=dc13589369b1, content=一直显示 pending approve 什么意思啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/amodRXMprCWV9f2xZ5KibibeL361ffy7OTCYbicgKiayK7b1bVNLdgsP3VKZLDMTfohbzHDnOcS6WHiaq7MAGDggrLw/132, createdBy=69ab2341096, createdName=wwlqd, createdTime=Tue Apr 21 10:49:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093944, encodeId=9e4f20939440e, content=偏重的研究方向：生信 经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=124a12bbm27暂无昵称, createdTime=Sat Oct 15 17:37:52 CST 2022, time=2022-10-15, status=1, ipAttribution=)]

2020-04-21 wwlqd

一直显示 pending approve 什么意思啊?

134 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=958807, encodeId=acd095880e5a, content=偏重的研究方向：肿瘤 经验分享：有人跟我一样三个月了连审稿人都没有的吗？害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1875413047, createdName=ms7000000322107334, createdTime=Tue Apr 20 18:00:47 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242321, encodeId=dce0124232100, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：杂志估计扩刊了，涌入了大量的纯生信文章，更让人惊讶的是没有收版面费！！！有没有类似的同道?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=马-龙, createdTime=Wed Aug 31 17:24:03 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227861, encodeId=47c9122e86161, content=投稿15天状态变成AE invited，一周后又变成submitted，请问各位老师这是什么操作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a76430084, createdName=ms3000000091174664, createdTime=Tue Jun 21 22:11:31 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944079, encodeId=5a269440e9e2, content=请问哪位大神，一个月前投了一篇，半个月前稿件状态已经显示的是AE assigned，现在稿件状态又变成submitted，请问这是怎么回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Sun Feb 28 08:29:25 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919514, encodeId=1241919514db, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：8月27投稿，12月24修稿，12月31号修回，1月7号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41072429587, createdName=123b2bbam96暂无昵称, createdTime=Sun Jan 24 18:32:16 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096197, encodeId=1866209619e86, content=submitted差不多2周了，还是editor unassigned 不知道要多久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Wed Oct 26 07:22:22 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104385, encodeId=cd05210438598, content=偏重的研究方向：网药;病理学 经验分享：被master journal list on hold了，搞不好这个月底被踢出sci核心集, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=780b8246335, createdName=ms7000002026112309, createdTime=Mon Dec 05 12:49:07 CST 2022, time=2022-12-05, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1238535, encodeId=c41c123853511, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤方向;meta-analysis 经验分享：2022.5.30提交 2022.7.17返修 2022.7.24回修完成 2022.8.13接受 感觉整体挺快的，评审提的意见也很到位，只要逐点回答，态度诚恳就可以啦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22546576496, createdName=ms5000000843589302, createdTime=Sat Aug 13 21:24:43 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589369, encodeId=dc13589369b1, content=一直显示 pending approve 什么意思啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/amodRXMprCWV9f2xZ5KibibeL361ffy7OTCYbicgKiayK7b1bVNLdgsP3VKZLDMTfohbzHDnOcS6WHiaq7MAGDggrLw/132, createdBy=69ab2341096, createdName=wwlqd, createdTime=Tue Apr 21 10:49:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093944, encodeId=9e4f20939440e, content=偏重的研究方向：生信 经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=124a12bbm27暂无昵称, createdTime=Sat Oct 15 17:37:52 CST 2022, time=2022-10-15, status=1, ipAttribution=)]

2022-10-15 124a12bbm27暂无昵称

偏重的研究方向：生信
经验分享：这杂志还收纯生信吗，10月14号刚刚投了一篇，不知道什么时候才能分配给编辑，会不会要等好久呢

38 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务